Skip to content

Comparative Study of Intravenous versus Perineural Dexamethasone as an Adjuvant to Bupivacaine in Transversus Abdominis Plane Block for Postoperative Analgesia in Cesarean Section”

Comparative Study of Intravenous Versus Perineural Dexamethasone Added To TAP Block For Analgesia After Cesarean Section. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097137
Enrollment
60
Registered
2025-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication Health Condition 2: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: Ultrasound guided Perineural dexamethasone with TAP block: Ultrasound guided 6mg perineural dexamethasone with TAP block for analgesia after cesarean section Control Intervention1: Intr

Sponsors

Sapthagiri Institute of medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with an American Society of Anesthesiologists (ASA) score of I,II,III who were scheduled for cesarean section under spinal anesthesia were included in the study

Exclusion criteria

Exclusion criteria: 1.Refusal to participate in the study Known allergies to local anesthetics or opioids or nonsteroidal anti-inflammatory drugs 2.Presence of infection at the needle entry site for the block 3. Use of chronic pain medications 4. Platelet count of less than 50000 cells per mm

Design outcomes

Primary

MeasureTime frame
We hypothesise that the duration of analgesia with perineural dexamethasone 6mg is greater than intravenous 6mg dexamethasoneTimepoint: 15min,30min,1hour, 2hour, 4hours 6hours 12hours, 24hrs,

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Prashanth prabhu j

Saptagiri institute of medical Sciences

prashanthjnpl@gmail.com9035067161

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026